早期和晚期发生的巴西前列腺癌患者的生殖线变异
Karoline Brito Caetano Andrade Coelho1, Jeremy A Squire2, Kelly Gomes Duarte1
1Surgery and Anatomy Department, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
Urologic oncology
|February 4, 2024
概括
这项研究在巴西前列腺癌 (PCa) 患者中发现了新的遗传变异,特别是在KMT2C基因中,为早期发病的PCa和特定人群的遗传因素提供了新的见解.
科学领域:
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 前列腺癌 (PCa) 中位数诊断年龄为66岁,但10%发生在55岁之前.
- 早期发病的PCa研究是有限的和有争议的.
- 巴西PCa患者的生殖线变异被调查为早期或晚期发病.
研究的目的:
- 在巴西PCa患者中识别和描述生殖系变异.
- 在早期和晚期的PCa.中区分遗传因素.
- 探索特定基因在跨年龄组PCa发展中的作用.
主要方法:
- 在71名PCa患者 (18名年轻人,53名老年人) 中对20个基因进行了向DNA测序.
- 目标基因参与了DNA损伤反应,转录调节,细胞周期和表观遗传控制.
- 在基分析预测了已识别的遗传变异的功能影响.
主要成果:
- 在两个年龄组中观察到BRCA2和KMT2C基因变异的更高频率.
- 在巴西PCa患者中发现了KMT2C基因变异,包括7种有害变异和4种新型变异 (1种致病性变异).
- 十三种有害变异是年轻的PCa组独有的.
结论:
- 这些发现增强了对巴西人口跨年龄组PCa遗传易感性的理解.
- 这是巴西年轻PCa患者生殖系变异的首次研究,突出了人口遗传多样性.
- 有害的KMT2C生殖系变体的证据表明它在PCa发展中的潜在作用,需要进一步研究.
相关概念视频
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...